Page last updated: 2024-09-03

reboxetine and Aging

reboxetine has been researched along with Aging in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carson, RE; Ding, YS; Gallezot, JD; Henry, S; Labaree, D; Malison, RT; Nabulsi, N; Neumeister, A; Planeta-Wilson, B; Ropchan, J; Singhal, T; Williams, W	1
Bercoff, E; Chiu, E; Katona, C; Tack, P; Versiani, M; Woelk, H	1
Fleishaker, JC	1

Reviews

1 review(s) available for reboxetine and Aging

Article	Year
Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression. Clinical pharmacokinetics, 2000, Volume: 39, Issue:6 Topics: Administration, Oral; Aged; Aging; Antidepressive Agents; Area Under Curve; Biological Availability; Female; Half-Life; Humans; Intestinal Absorption; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Protein Binding; Reboxetine; Stereoisomerism; Tissue Distribution	2000

Article

Year

Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression.

Clinical pharmacokinetics, 2000, Volume: 39, Issue:6

Topics: Administration, Oral; Aged; Aging; Antidepressive Agents; Area Under Curve; Biological Availability; Female; Half-Life; Humans; Intestinal Absorption; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Protein Binding; Reboxetine; Stereoisomerism; Tissue Distribution

2000

Trials

1 trial(s) available for reboxetine and Aging

Article	Year
Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial. Journal of affective disorders, 1999, Volume: 55, Issue:2-3 Topics: Aged; Aging; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Geriatric Psychiatry; Humans; Hypotension; Imipramine; Male; Morpholines; Reboxetine; Treatment Outcome	1999

Article

Year

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial.

Journal of affective disorders, 1999, Volume: 55, Issue:2-3

Topics: Aged; Aging; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Geriatric Psychiatry; Humans; Hypotension; Imipramine; Male; Morpholines; Reboxetine; Treatment Outcome

1999

Other Studies

1 other study(ies) available for reboxetine and Aging

Article	Year
PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT. Synapse (New York, N.Y.), 2010, Volume: 64, Issue:1 Topics: Adult; Aging; Brain; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reboxetine	2010

Article

Year

PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT.

Synapse (New York, N.Y.), 2010, Volume: 64, Issue:1

Topics: Adult; Aging; Brain; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reboxetine

2010